Punch & Associates Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Punch & Associates Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,247	Closed	-$218K	–	184
2023 Q4	$218K	Hold	4,247	–	–	0.01%	203
2023 Q3	$246K	Buy	4,247 +1,047	+33%	+$64.2K	0.02%	191
2023 Q2	$205K	Hold	3,200	–	–	0.01%	205
2023 Q1	$222K	Hold	3,200	–	–	0.01%	193
2022 Q4	$230K	Hold	3,200	–	–	0.01%	198
2022 Q3	$227K	Hold	3,200	–	–	0.02%	200
2022 Q2	$246K	Sell	3,200 -56	-2%	-$4.26K	0.02%	203
2022 Q1	$238K	Buy	3,256 +56	+2%	+$3.76K	0.01%	205
2021 Q4	$200K	Buy	+3,200	New	+$188K	0.01%	216
2021 Q3	–	Sell	-3,200	Closed	-$214K	–	242
2021 Q2	$214K	Hold	3,200	–	–	0.01%	219
2021 Q1	$202K	Buy	+3,200	New	+$199K	0.01%	223

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Punch & Associates Investment Management's BMY Position: Q1 2024 in Review

Punch & Associates Investment Management sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 4,247 shares — an estimated $218K sold.

Punch & Associates Investment Management first reported a position in BMY in Q1 2021 and held it in 11 quarters. The position peaked at $246K in Q3 2023. 2,332 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

Punch & Associates Investment Management reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
Punch & Associates Investment Management sold 4,247 Bristol-Myers Squibb shares in Q1 2024, an estimated $218K.
Punch & Associates Investment Management first reported a position in Bristol-Myers Squibb in Q1 2021 and held it in 11 quarters.
Punch & Associates Investment Management's Bristol-Myers Squibb position peaked at $246K in Q3 2023.
2,332 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Punch & Associates Investment Management's 13F filing for Q1 2024, filed 15 May 2024.